Use of bacterial phage associated lysing enzymes for treating streptococcal infections of the upper respiratory tract
US6936244B2 · kind B2 · utility
12Cited by
91References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 14, 2002 |
| Grant date | Aug 30, 2005 |
| Priority date | — |
| Expiry date | May 14, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition for treatment of bacterial infections of the eye is disclosed which comprises a lytic enzyme composition specific for the infecting bacteria, and a carrier for delivering said lytic enzyme. The carrier for delivering at least one lytic enzyme to the eye may be but is not limited to the use of an isotonic solution.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.